Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

Divi's Labs to spend Rs. 15-bn to expand manufacturing capacity

Divi's Labs to spend Rs. 15-bn to expand manufacturing capacity

2018-11-07

Divi's Labs to spend Rs. 15-bn to expand manufacturing capacity

Aurobindo recalls hypertensive drug in US

Aurobindo recalls hypertensive drug in US

2018-11-06

Aurobindo Pharma has initiated voluntary recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension from the US market due to the presence of an impurity, which is believed to cause cancer, the US Food and Drug Administration has

Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore

Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore

2018-11-06

Natco Pharma reported over two-fold increase in consolidated profit after tax at ₹ 181.6 crore for the second quarter ended September 30, 2018. The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter last fiscal, Natco P

Amazing Monthly Sales Performance of Opdivo and Keytruda in China

Amazing Monthly Sales Performance of Opdivo and Keytruda in China

2018-11-06

It was revealed that by September 30, i.e., about one month after the marketing in China, the sales revenue of the two anti-PD-1 monoclonal antibody drugs: Opdivo and Keytruda separately reached RMB 190 million and RMB 150 million, showing amazing perform

Link between early antibiotic exposure and weight gain in young children

Link between early antibiotic exposure and weight gain in young children

2018-11-05

A study conducted within the National Patient Centered Clinical Research Network (PCORnet) has found that antibiotic use at less than 24 months of age was associated with slightly higher body weight at 5 years of age.

GSK's anti-seizure drug shows promise in early depression study

GSK's anti-seizure drug shows promise in early depression study

2018-11-05

Researchers have found that GlaxoSmithKline’s ezogabine(Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatment for treatment-resistant depression.

Reliance Industries posts 17% increase in consolidated Q2 net profit

Reliance Industries posts 17% increase in consolidated Q2 net profit

2018-11-05

The consolidated net profit of Reliance Industries Ltd. (RIL) rose 17.4 per cent in the July-September quarter to Rs. 9,516-crore from a year ago as revenue from operations jumped 54.5 per cent to Rs. 1,56,291-crore. The consolidated net profit was Rs. 8,

FDA approves Colorcon’s iron oxide petition to expand colour spectrum

FDA approves Colorcon’s iron oxide petition to expand colour spectrum

2018-11-05

FDA approves Colorcon’s iron oxide petition to expand colour spectrum

Radhesh Welling appointed as Managing Director, Navin Fluorine

Radhesh Welling appointed as Managing Director, Navin Fluorine

2018-11-05

The Board of Directors of Navin Fluorine International Ltd. (NFIL) have, at their meeting held on October 22, 2018, approved the appointment of Mr. Radhesh Welling as Managing Director of the company for a period of five years with effect from December 11

PolyOne expands Pune plant with new TPE line and Technology Centre

PolyOne expands Pune plant with new TPE line and Technology Centre

2018-11-05

PolyOne has announced the opening of a new, state-of-the-art thermoplastic elastomer (TPE) production line at its Pune facility. In addition, the company opened a new Technology Centre that will house an advanced laboratory for new and existing R&D ac

Hindustan Zinc ranked at top in sustainability index

Hindustan Zinc ranked at top in sustainability index

2018-11-05

Hindustan Zinc Ltd. (HZL), a Vedanta Group company and India’s only integrated zinc-lead-silver producer, has announced that it has been ranked first in Environment category and overall fifth in the Metals & Mining sector by the Dow Jones Sustainabili

Alembic announces successful USFDA inspection at joint venture

Alembic announces successful USFDA inspection at joint venture

2018-11-05

Aleor was formed in April 2016 to develop, manufacture and commercialise dermatology products for worldwide markets. Till date the company has filed six ANDAs.

PIL seeks curbs on antibiotics sale without prescription

PIL seeks curbs on antibiotics sale without prescription

2018-11-05

A Mumbai-based lawyer has filed a public interest litigation (PIL) before the Bombay High Court seeking a directive to restrict over-the-counter sale of antibiotics in India, the world’s “largest consumer of antibiotics”.

Suven presents Alzheimer drug findings in Barcelona

Suven presents Alzheimer drug findings in Barcelona

2018-11-01

Suven presents Alzheimer drug findings in Barcelona

SCHOTT Tubing India to boost capacity at Gujarat facility

SCHOTT Tubing India to boost capacity at Gujarat facility

2018-11-01

SCHOTT Tubing India to boost capacity at Gujarat facility

PIL seeks curbs on antibiotics sale without prescription

PIL seeks curbs on antibiotics sale without prescription

2018-11-01

PIL seeks curbs on antibiotics sale without prescription

Dr. Reddy's receives approval for aspirin and extended-release dipyridamole

Dr. Reddy's receives approval for aspirin and extended-release dipyridamole

2018-11-01

Dr. Reddy's receives approval for aspirin and extended-release dipyridamole

Big pharma companies plan cheaper alternatives for Ayushman Bharat insurance

Big pharma companies plan cheaper alternatives for Ayushman Bharat insurance

2018-11-01

Big pharma companies plan cheaper alternatives for Ayushman Bharat insurance

Alembic Pharmaceuticals posts strong Q2 results

Alembic Pharmaceuticals posts strong Q2 results

2018-11-01

Alembic Pharmaceuticals posts strong Q2 results

Alembic announces successful USFDA inspection at joint venture

Alembic announces successful USFDA inspection at joint venture

2018-11-01

Alembic announces successful USFDA inspection at joint venture

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message